Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study.

Stavroula A PaschouVangelis KaralisTheodora PsaltopoulouIoanna CharitakiAimilia D SklirouVassiliki A IconomidouVasiliki VasileiouGeorgia N KassiAndromachi VryonidouAlexander KokkinosNicholas TentolourisErifili HatziaggelakiIoannis P TrougakosEvangelos TerposMeletios Athanasios Dimopoulos

Published in: Hormones (Athens, Greece) (2022)

Patients with T2DM present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to that of healthy subjects.

Keyphrases

coronavirus disease
sars cov
glycemic control
binding protein
respiratory syndrome coronavirus
cardiovascular disease
skeletal muscle